BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 34204372)

  • 1. Current Perspectives on the Role of Matrix Metalloproteinases in the Pathogenesis of Basal Cell Carcinoma.
    Tampa M; Georgescu SR; Mitran MI; Mitran CI; Matei C; Caruntu A; Scheau C; Nicolae I; Matei A; Caruntu C; Constantin C; Neagu M
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34204372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer.
    Kerkelä E; Saarialho-Kere U
    Exp Dermatol; 2003 Apr; 12(2):109-25. PubMed ID: 12702139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases in keratinocyte carcinomas.
    Riihilä P; Nissinen L; Kähäri VM
    Exp Dermatol; 2021 Jan; 30(1):50-61. PubMed ID: 32869366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Matrix Metalloproteinases in Photoaging and Photocarcinogenesis.
    Pittayapruek P; Meephansan J; Prapapan O; Komine M; Ohtsuki M
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27271600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXC chemokine receptor CXCR4 expression enhances tumorigenesis and angiogenesis of basal cell carcinoma.
    Chen GS; Yu HS; Lan CC; Chow KC; Lin TY; Kok LF; Lu MP; Liu CH; Wu MT
    Br J Dermatol; 2006 May; 154(5):910-8. PubMed ID: 16634895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction.
    Tjiu JW; Chen JS; Shun CT; Lin SJ; Liao YH; Chu CY; Tsai TF; Chiu HC; Dai YS; Inoue H; Yang PC; Kuo ML; Jee SH
    J Invest Dermatol; 2009 Apr; 129(4):1016-25. PubMed ID: 18843292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases 2 and 9, and extracellular matrix in Kaposi's sarcoma.
    Bongiorno MR; Doukaki S; Ferro G; Aricò M
    Dermatol Ther; 2010; 23 Suppl 2():S33-6. PubMed ID: 20482566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of COX-2 in recurrent basal cell carcinoma of the skin: a pilot study.
    Karahan N; Baspinar S; Bozkurt KK; Caloglu E; Ciris IM; Kapucuoglu N
    Indian J Pathol Microbiol; 2011; 54(3):526-31. PubMed ID: 21934214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical analysis of TIMP-3 and MMP-9 in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.
    Poswar FO; Fraga CA; Farias LC; Feltenberger JD; Cruz VP; Santos SH; Silveira CM; de Paula AM; Guimarães AL
    Pathol Res Pract; 2013 Nov; 209(11):705-9. PubMed ID: 24011615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer.
    Radisky ES; Raeeszadeh-Sarmazdeh M; Radisky DC
    J Cell Biochem; 2017 Nov; 118(11):3531-3548. PubMed ID: 28585723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of basement membrane antigens and matrix metalloproteinases 2 and 9 in cutaneous basal and squamous cell carcinomas.
    Dumas V; Kanitakis J; Charvat S; Euvrard S; Faure M; Claudy A
    Anticancer Res; 1999; 19(4B):2929-38. PubMed ID: 10652575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axillary basal cell carcinoma--a rare form of a frequent kind of carcinoma.
    Costescu M; Coman OA; Tampa M; Tudose I; Coman L; Georgescu SR
    Rom J Morphol Embryol; 2013; 54(3 Suppl):851-6. PubMed ID: 24322039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis].
    Fink K; Boratyński J
    Postepy Hig Med Dosw (Online); 2012 Sep; 66():609-28. PubMed ID: 23001203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer associated fibroblasts (CAFs) are activated in cutaneous basal cell carcinoma and in the peritumoural skin.
    Omland SH; Wettergren EE; Mollerup S; Asplund M; Mourier T; Hansen AJ; Gniadecki R
    BMC Cancer; 2017 Oct; 17(1):675. PubMed ID: 28987144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase inhibitors.
    Wojtowicz-Praga SM; Dickson RB; Hawkins MJ
    Invest New Drugs; 1997; 15(1):61-75. PubMed ID: 9195290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggressive basal cell carcinoma: presentation, pathogenesis, and management.
    Walling HW; Fosko SW; Geraminejad PA; Whitaker DC; Arpey CJ
    Cancer Metastasis Rev; 2004; 23(3-4):389-402. PubMed ID: 15197337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression of matrix metalloproteinase-1 (interstitial collagenase) and matrix metalloproteinase-3 (stromelysin-1) in basal cell carcinoma by in situ hybridization using chondroitin ABC lyase.
    Tsukifuji R; Sakai Y; Hatamochi A; Shinkai H
    Histochem J; 1997 May; 29(5):401-7. PubMed ID: 9184854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the microvasculature of basal cell carcinoma and actinic keratosis using intravital microscopy and immunohistochemistry.
    Newell B; Bedlow AJ; Cliff S; Drysdale SB; Stanton AW; Mortimer PS
    Br J Dermatol; 2003 Jul; 149(1):105-10. PubMed ID: 12890202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases and cancer - roles in threat and therapy.
    Yadav L; Puri N; Rastogi V; Satpute P; Ahmad R; Kaur G
    Asian Pac J Cancer Prev; 2014; 15(3):1085-91. PubMed ID: 24606423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of tumor angiogenesis in nonaggressive and aggressive basal cell carcinoma of the human skin.
    Staibano S; Boscaino A; Salvatore G; Orabona P; Palombini L; De Rosa G
    Hum Pathol; 1996 Jul; 27(7):695-700. PubMed ID: 8698314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.